Why Charles River Laboratories International, Inc. (CRL) stock moved
Charles River Laboratories International, Inc. (CRL) shares rose 1.3% to $295.19 as of August 22, 2026, a modest gain from the prior close of $291.45. BestStocks flagged the session as a major change for CRL. The move is tied to price move up. Below, we break down what changed for CRL, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CRL climbed 1.3% to $295.19
Charles River Laboratories International, Inc. (CRL) moved +2.01% from $285.72 to $291.45 on 2026-08-20, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. CRL earnings are scheduled for 2026-11-04; consensus EPS estimate is $2.98.
What it means for Charles River Laboratories International, Inc. investors
For Charles River Laboratories International, Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Material positive event; Positive 1.3% session move. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $267.60, implying -9.3% downside from $295.19. Over the past 90 days analysts logged 3 upgrades and 1 downgrade. BestStocks rates the overall signal quality weak (38/100). With earnings roughly 74 days out, the next report is the most likely near-term test of the move.
CRL price reaction
CRL last traded at $295.19, up $3.74 (+1.28%) from the previous close of $291.45. The session traded on 0.8× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $218.70 and $295.19, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on Charles River Laboratories International, Inc. (CRL)
The consensus analyst price target on Charles River Laboratories International, Inc. (CRL) is $267.60, 9.3% below the recent $295.19. Over the past 90 days analysts logged 3 upgrades, 6 maintains, and 1 downgrade. Here is how the bullish and bearish cases on CRL line up.
The bullish case
- The Street's most bullish target is $300.00 (+1.6%).
- 3 analyst upgrades in the past 90 days, most recently JP Morgan to Overweight (2026-08-06).
- Material positive event.
- Positive 1.3% session move.
- Charles River Laboratories International, Inc. (CRL) moved +3.50% from $267.62 to $277.00 on 2026-08-10, reaching a new 30-day high.
The bearish case
- The consensus analyst price target of $267.60 sits 9.3% below the recent $295.19, so the average target sees limited room to run.
- The most bearish analyst target is $219.00 (-25.8%).
- 1 analyst downgrade in the past 90 days, most recently CLSA to Hold (2026-07-20).
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 22, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CRL
Frequently asked questions about CRL
Why did Charles River Laboratories International, Inc. (CRL) stock move?
CRL rose 1.3% to $295.19. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did CRL stock rise?
CRL gained 1.28% ($3.74) versus the prior close of $291.45, last trading at $295.19 on 0.8× average volume.
When is Charles River Laboratories International, Inc.'s next earnings date?
CRL's next earnings report is estimated for 2026-11-04 — about 74 days away.
What is the analyst price target for CRL?
The consensus analyst price target for CRL is $267.60, about 9.3% below the current $295.19. Over the past 90 days, analysts recorded 3 upgrades, 6 maintains, and 1 downgrade.
How BestStocks tracks CRL
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for CRL, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 22, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.